Livre Blanc
Agility to compete: From promotion to participation
Nov 18, 2026
Download
The economics of growth are becoming more challenging, while influence across the healthcare ecosystem is shifting and fragmenting. Together, these forces are creating an imperative for pharma to evolve beyond a predominantly HCP centred commercial model. While that model will remain important and become increasingly sophisticated through technology, this paper draws on lessons from other industries to explore a future in which pharma operates through a portfolio of coexisting models: business-to-consumer, business-to-business, and business-to-ecosystem.